Teva Pharmaceuticals
TEVA
TEVA
811 hedge funds and large institutions have $30B invested in Teva Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 304 increasing their positions, 298 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $32.1B → $30B (-$2.11B)
23% less funds holding in top 10
Funds holding in top 10: 53 → 41 (-12)
24% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 75
Holders
811
Holding in Top 10
41
Calls
$945M
Puts
$717M
Top Buyers
| 1 | +$672M | |
| 2 | +$335M | |
| 3 | +$287M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$220M |
| 5 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$199M |
Top Sellers
| 1 | -$482M | |
| 2 | -$275M | |
| 3 | -$263M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$205M |
| 5 |
PC
Paulson & Co
New York
|
-$192M |